Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Flexray Medical ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   1.4% 2.2% 1.0% 1.2% 1.3% 1.7% 8.1% 8.1%   Credit score (0-100)   80 67 86 80 79 71 30 30   Credit rating   A BBB A A A A BB BB   Credit limit (kDKK)   61.7 0.1 565.8 225.2 125.9 11.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,912 1,627 5,539 5,481 4,275 4,694 0.0 0.0   EBITDA   2,095 86.0 3,632 3,095 1,211 2,037 0.0 0.0   EBIT   2,089 79.0 3,623 3,084 1,200 2,032 0.0 0.0   Pre-tax profit (PTP)   2,035.0 114.0 3,417.0 3,109.0 1,130.2 2,207.6 0.0 0.0   Net earnings   1,573.0 78.0 2,661.0 2,417.0 860.0 1,698.5 0.0 0.0   Pre-tax profit without non-rec. items   2,035 114 3,417 3,109 1,130 2,208 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   29.0 22.0 34.0 23.0 11.3 6.1 0.0 0.0   Shareholders equity total   4,166 3,939 5,100 6,766 7,226 8,524 7,670 7,670   Interest-bearing liabilities   10.0 42.0 74.0 119 53.8 0.0 0.0 0.0   Balance sheet total (assets)   10,470 7,260 10,659 8,320 12,677 10,588 7,670 7,670   Net Debt   -5,555 -3,495 -4,572 -2,129 -5,061 -8,248 -7,670 -7,670     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,912 1,627 5,539 5,481 4,275 4,694 0.0 0.0   Gross profit growth   55.4% -58.4% 240.4% -1.0% -22.0% 9.8% -100.0% 0.0%   Employees   3 3 3 3 4 4 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 33.3% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   10,470 7,260 10,659 8,320 12,677 10,588 7,670 7,670   Balance sheet change%   74.1% -30.7% 46.8% -21.9% 52.4% -16.5% -27.6% 0.0%   Added value   2,095.0 86.0 3,632.0 3,095.0 1,210.9 2,037.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   23 -14 3 -22 -23 -10 -6 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   53.4% 4.9% 65.4% 56.3% 28.1% 43.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   25.5% 1.4% 40.4% 33.4% 11.5% 19.6% 0.0% 0.0%   ROI %   61.5% 3.1% 79.1% 52.5% 17.0% 28.9% 0.0% 0.0%   ROE %   46.5% 1.9% 58.9% 40.7% 12.3% 21.6% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   40.6% 54.3% 47.8% 81.3% 58.7% 87.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -265.2% -4,064.0% -125.9% -68.8% -417.9% -404.9% 0.0% 0.0%   Gearing %   0.2% 1.1% 1.5% 1.8% 0.7% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   264.0% 46.2% 355.2% 58.0% 88.4% 289.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.3 1.7 1.8 4.5 2.1 7.1 0.0 0.0   Current Ratio   1.7 2.2 1.9 5.3 2.3 5.2 0.0 0.0   Cash and cash equivalent   5,565.0 3,537.0 4,646.0 2,248.0 5,115.3 8,247.8 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   4,103.0 3,875.0 5,022.0 6,696.0 7,164.0 8,493.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   698 29 1,211 1,032 303 509 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   698 29 1,211 1,032 303 509 0 0   EBIT / employee   696 26 1,208 1,028 300 508 0 0   Net earnings / employee   524 26 887 806 215 425 0 0